Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

Clinical trial NCT05012098 · COMPLETED

Trial details

NCT number: NCT05012098
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Olfactory Neuroblastoma Esthesioneuroblastoma Neoplasm of the Nasal Cavity

Start date: 2022-06-21
Primary completion: 2024-07-09
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.